Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Beam Therapeutics Inc. | CEO, Director | Common Stock | 998K | $24.5M | $24.50 | Jun 27, 2024 | Direct |
Beam Therapeutics Inc. | CEO, Director | Common Stock | 103K | $2.52M | $24.50 | Jun 27, 2024 | By John M. Evans, III 2018 Irrevocable Trust |
Beam Therapeutics Inc. | CEO, Director | Stock Option (Right to Buy) | 54K | $1.32M | $24.40 | Apr 3, 2024 | Direct |
Verve Therapeutics, Inc. | Director | Stock Option (right to buy) | 15.5K | Jun 9, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BEAM | Beam Therapeutics Inc. | Jun 27, 2024 | 1 | -$1.47M | 4 | Jun 28, 2024 | CEO, Director |
BEAM | Beam Therapeutics Inc. | Apr 1, 2024 | 3 | -$582K | 4 | Apr 3, 2024 | CEO, Director |
BEAM | Beam Therapeutics Inc. | Mar 28, 2024 | 2 | -$2.03M | 4 | Apr 1, 2024 | CEO, Director |
BEAM | Beam Therapeutics Inc. | Jan 31, 2024 | 2 | $2.26M | 4 | Feb 2, 2024 | CEO, Director |
BEAM | Beam Therapeutics Inc. | Apr 3, 2023 | 2 | -$345K | 4 | Apr 5, 2023 | CEO, Director |
BEAM | Beam Therapeutics Inc. | Jan 31, 2023 | 5 | $100K | 4 | Mar 31, 2023 | CEO, Director |
BEAM | Beam Therapeutics Inc. | Oct 31, 2022 | 8 | -$2.32M | 4 | Nov 2, 2022 | CEO, Director |
BEAM | Beam Therapeutics Inc. | Jul 28, 2022 | 9 | -$3.29M | 4 | Jul 29, 2022 | CEO, Director |
VERV | Verve Therapeutics, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
BEAM | Beam Therapeutics Inc. | Apr 28, 2022 | 14 | -$1.76M | 4 | May 2, 2022 | CEO, Director |
BEAM | Beam Therapeutics Inc. | Mar 31, 2022 | 2 | -$370K | 4 | Apr 4, 2022 | CEO, Director |
BEAM | Beam Therapeutics Inc. | Jan 31, 2022 | 16 | -$3.24M | 4/A | Feb 2, 2022 | CEO, Director |
BEAM | Beam Therapeutics Inc. | Oct 6, 2021 | 10 | -$3.97M | 4 | Oct 8, 2021 | CEO, Director |
BEAM | Beam Therapeutics Inc. | Aug 19, 2021 | 8 | -$1.98M | 4 | Aug 20, 2021 | CEO, Director |
BEAM | Beam Therapeutics Inc. | Jul 7, 2021 | 15 | -$2.67M | 4 | Jul 8, 2021 | CEO, Director |
BEAM | Beam Therapeutics Inc. | Jun 25, 2021 | 3 | $0 | 4 | Jun 30, 2021 | Chief Executive Officer, Director |
VERV | Verve Therapeutics, Inc. | Jun 16, 2021 | 0 | $0 | 3 | Jun 16, 2021 | Director |
BEAM | Beam Therapeutics Inc. | Feb 5, 2020 | 2 | $0 | 4/A | Sep 21, 2021 | CEO, Director |